Search - tctmd.com

Displaying 61 - 80 of 125

Sort: Relevancy | Date

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News CV Team Pro

Bailey Ann Estes

L.A. McKeown

July 11, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Opinion Off Script

UPDATED A Cardiologist in Kyiv: ‘I Hope for the Best’

Sergey Kozhukhov, MD, PhD

April 01, 2022

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Conference News EAS 2021

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Michael O'Riordan

June 04, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

Advertisement

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

TCTMD’s Top 10 Most Popular Stories for July 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

Bailey Ann Estes

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

TCTMD’s Top 10 Most Popular Stories for April 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

UPDATED A Cardiologist in Kyiv: ‘I Hope for the Best’

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

More Insights Into AAA Genetics Spur New Questions on Screening

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content